Report Id: SNS/HC/1828 | June 2022 | Region: Global | 125 Pages
Report Scope & Overview:
The Healthcare BPO Market Size was valued at USD 327.86 billion in 2022 and is expected to reach USD 692.64 billion by 2030, and grow at a CAGR of 9.8% over the forecast period 2023-2030.
Healthcare Business Process Outsourcing (BPO) is a method that allows healthcare organisations to choose the best third-party vendors for certain business operations. As a result, medical professionals and hospitals must devote more of their time to patient care. It is an option for clients that are willing to accept clever ways that benefit the organisation by lowering costs and enhancing overall productivity. The Healthcare BPO Market delivers solutions such as Medicare services, pharmaceutical benefits administration, and provider network services.
Clinical Process Outsourcing is Increasing at a Rapid Pace
The passage of the Patient Protection and Affordable Care Act (PPACA) forced healthcare providers to outsource.
In the pharmaceutical and biopharmaceutical industries, outsourcing is becoming more common.
There is a lot of pressure to cut healthcare expenses because they are skyrocketing.
Increased Access to Technology and Nearshore Outsourcing Destinations
Outsourcing charges that aren't disclosed
Loss of visibility and control over the business process is a source of concern.
Data analytics of the highest level
Artificial intelligence-based drug discovery techniques are becoming increasingly popular.
Data collection in Medicaid programmes has some limitations.
Concerns about data privacy
IMPACT OF COVID-19
The COVID 19 epidemic, which is affecting the entire world, has had a devastating effect on the lives of many people. The economy is in a shambles due to closing time and closing time. This has forced the economy into an inevitable recession. As a result, coping with the new set of epidemics has proved challenging. The healthcare industry is weakening due to the outbreak of coronavirus, as most BPO workers live in remote areas and are forced to leave their homes due to the epidemic.
COVID 19 has had a profound effect on how people work and live. Companies should develop their strategies after a thorough examination of the BPO healthcare market and in line with market demand to return to normalcy. The release of the health care business process is likely to return in the second half of this year, according to Healthcare BPO Market.
By Provider Service Type
Revenue Cycle Management, Patient Enrollment & Strategic Planning, and Patient Care are the three segments that make up the market. Medical Transcription, Medical Imaging, and Device Monitoring are the three segments that make up the Patient Care segment. The most rapid expansion is seen in the Revenue Cycle Management area. This is due to an increase in the number of cases of billing errors and reimbursement errors. The hospital staff must devote a significant amount of time to these processes. These issues are efficiently resolved by professionals when they are outsourced, saving time.
By Payer Service Type
Claims Management, Member Management, Provider Management, Product Development and Business Acquisition, Integrated Front-end Services & Back-office Operations, Care Management, Billing & Accounts Management Services, and HR Services are the categories in which the industry is divided. The fastest-growing segment is expected to be Product Development and Business Acquisition. This is due to an increase in the number of people purchasing health insurance and plans. As a result, providers must seek guidance on how to mitigate the risks involved.
By Pharmaceutical Services Type
Manufacturing Services, R&D Services, and Non-clinical Services are the three segments of the market. Sales & Marketing Service, SCM, and Other Non-clinical Services are divided into the non-Clinical category. The Non-Clinical Services segment is expected to increase at the fastest rate. Pricing pressure and the need for big field forces are to blame for this.
Some of the major key players of Healthcare BPO Market are as follows: Accenture, IQVIA, Cognizant Technology Solutions Corp, Accretive Health, Lonza Group AG, Genpact Ltd, Infosys BPO Ltd, Xerox Corp, Tata Consultancy Services Ltd, Quintiles, Inc.
By Provider Service Type
Revenue Cycle Management
By Payer Service Type
Integrated Front-end Services and Back-office Operations
Member Management Product Development and Business Acquisition (PDBA)
Provider Management Care Management
Billing & Accounts Management Services
By Pharmaceutical Services Type
Sales & Marketing Services
North America dominated the healthcare BPO industry, followed by Europe and the Rest of the World. Pharmaceutical businesses in the region, particularly in the United States, are under considerable price pressures as a result of the Medicare Prescription Medication Coverage (Part D) program, which provides prescription drug coverage to all Medicare beneficiaries. Furthermore, the patent expiration of some blockbuster pharmaceuticals is projected to have an impact on large pharmaceutical companies' revenue in the United States and Canada. Taking these aspects into account, a number of pharmaceutical companies are focused on cost reduction through outsourcing, which is propelling the market in North America forward.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 327.86 Billion|
|Market Size by 2030||US$ 692.64 Billion|
|CAGR||CAGR of 9.8% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Provider Service Type (Revenue Cycle Management, Patient Enrollment, Patient Care)
• By Payer Service Type (Claims Management, Integrated Front-end Services and Back-office Operations, Member Management Product Development and Business Acquisition (PDBA), Provider Management Care Management, Billing & Accounts Management Services, HR Services)
• By Pharmaceutical Services Type (Manufacturing Services, R&D Services, Non-clinical Services, Sales & Marketing Services, SCM)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Accenture, IQVIA, Cognizant Technology Solutions Corp, Accretive Health, Lonza Group AG, Genpact Ltd, Infosys BPO Ltd, Xerox Corp, Tata Consultancy Services Ltd, Quintiles, Inc.|
|DRIVERS||• Clinical Process Outsourcing is Increasing at a Rapid Pace
• The passage of the Patient Protection and Affordable Care Act (PPACA) forced healthcare providers to outsource.
• In the pharmaceutical and biopharmaceutical industries, outsourcing is becoming more common.
|RESTRAINTS||• Outsourcing charges that aren't disclosed
• Loss of visibility and control over the business process is a source of concern.
Frequently Asked Questions (FAQ) :
North America dominated the healthcare BPO industry, followed by Europe and the Rest of the World.
Revenue Cycle Management, Patient Enrollment, Patient Care are the sub segments of Healthcare BPO market.
Key drivers of the Healthcare BPO Market is there is a lot of pressure to cut healthcare expenses because they are skyrocketing, Increased Access to Technology and Nearshore Outsourcing Destinations.
Healthcare Business Process Outsourcing (BPO) is a method that allows healthcare organisations to choose the best third-party vendors for certain business operations. As a result, medical professionals and hospitals must devote more of their time to patient care.
Healthcare BPO Market Size was valued at USD 298.6billion in 2021, and expected to reach USD 574.6 billion by 2028.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
18.104.22.168 United Kingdom
22.214.171.124 South Korea
126.96.36.199 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Healthcare BPO Market Segmentation by Provider Service Type
8.1 Revenue Cycle Management
8.2 Patient Enrollment
8.3 Patient Care
9. Healthcare BPO Market Segmentation, By Payer Service Type
9.1 Claims Management
9.2 Integrated Front-end Services and Back-office Operations
9.3 Member Management Product Development and Business Acquisition (PDBA)
9.4 Provider Management Care Management
9.5 Billing & Accounts Management Services
9.6 HR Services
10. Healthcare BPO Market Segmentation, By Pharmaceutical Services Type
10.1 Manufacturing Services
10.2 R&D Services
10.3 Non-clinical Services
10.4 Sales & Marketing Services
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.3 Cognizant Technology Solutions Corp
12.4 Accretive Health
12.5 Lonza Group AG
12.6 Genpact Ltd
12.7 Infosys BPO Ltd
12.8 Xerox Corp
12.9 Tata Consultancy Services Ltd
12.10 Quintiles, Inc.
13.1 Competitive Benchmark
13.2 Market Share analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.